Admission to Trading
Summary by AI BETAClose X
3 November 2026
HSBC BANK PLC
ISSUANCE OF NOTES
AND ADMISSION TO TRADING
On 3 November 2026, HSBC Bank plc issued the Notes (as defined below) under its Notes and Warrants Programme (the "Programme").
In accordance with PRM 1.5.2R and PRM 1.5.3R of the Financial Conduct Authority's ("FCA") Handbook Prospectus Rules: Admission to Trading on a Regulated Market sourcebook, HSBC Bank plc notifies the market that the Notes have been listed on the Official List of the FCA and admitted to trading on the Main Market of the London Stock Exchange plc as follows:
|
Issuer name: |
HSBC Bank plc |
|
Issuer LEI: |
MP6I5ZYZBEU3UXPYFY54 |
|
Regulated market on which the securities have been admitted to trading: |
Main Market of the London Stock Exchange plc |
|
Name, type and ISIN of the securities and number of securities admitted to trading: |
GBP 735,537 Notes linked to UKSED3P Investments Limited series 3663 (ISIN: XS3379569638);
GBP 737,399 Notes linked to UKSED3P Investments Limited series 3662 (ISIN: XS3379569398);
GBP 1,124,866 Notes linked to UKSED3P Investments Limited series 3661 (ISIN: XS3379569554); and
GBP 968,696 Notes linked to UKSED3P Investments Limited series 3660 (ISIN: XS3379569125),
collectively, the "Notes".
|
|
Date of admission to trading: |
3 November 2026 |
|
Date of prospectus relating to the securities: |
The base prospectus relating to the Programme dated 12 June 2026, under which the Notes have been issued, is available for viewing at www.hsbc.com (follow links to 'Investors', 'Fixed income investors' and 'Issuance Programmes'). Separate final terms dated 14 September 2026, in respect of Notes is available for viewing at www.hsbc.com (follow links to 'Investors', 'Fixed income investors' and 'Final terms and supplements'). |
more
For any queries, please contact your usual HSBC sales representative.
DISCLAIMER - INTENDED ADDRESSEES
The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘Securities Act’), or any state securities laws and, unless so registered, may not be offered or sold within the United States or to, or for the account or the benefit of, US persons, as defined in Regulation S under the Securities Act, except pursuant to an exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
ends/all
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 11 hours ago Luceco
- 11 hours ago Helios Towers
- 12 hours ago Wise Class A
- 12 hours ago EDX Medical Group Plc
- 12 hours ago Naked Wines